뇌질환의 혁신, 뉴로벤티(NeuroVenti)

ABOUT

NeuroVenti contributes to creating a society where we work together.

NeuroVenti is dedicated to a society defined by brain well-being.



NeuroVenti is a biotechnology company developing small-molecule therapeutics for neurodevelopmental conditions, including autism spectrum disorder(ASD) and ASD-related conditions such as Fragile X syndrome(FXS). Our pipeline comprises multi-target candidates advancing into Phase II clinical trials. We also operate a contract research organization (see CDRO note, F6), providing drug discovery and pre-clinical efficacy and safety evaluation for candidate molecules directed at central nervous system(CNS) disorders — spanning neurological, psychiatric, and neurodevelopmental disease.
Drug Development Drug Development
  • 1Neurodevelopmental disorders
    • Autism spectrum disorder (ASD)
    • ADHD
  • 2Intractable brain disease
뇌질환 치료제 후보발굴 서비스 CNS disorders’
therapeutic candidates research service
  • 1Preclinical research consulting
  • 2CNS disease-related research service
  • 3One-stop in vitro & in vivo efficacy test
Platform technology Platform technology
  • 1Precision medicine
  • 2Electroceuticals
  • 3Health care solution